Savencia (BGJ) Price & Analysis

0 Followers

BGJ Stock Chart & Stats

€61.60

€0.40(0.79%)

At close: Jan 08 4:00 PM EST

€61.60

€0.40(0.79%)

Day’s Range― - ―

52-Week Range€53.80 - €73.60

Previous CloseN/A

Volume50.00

Average Volume (3M)0.00

Market Cap

€768.04M

Enterprise Value€2.09B

Total Cash (Recent Filing)€726.99M

Total Debt (Recent Filing)€1.70B

Price to Earnings (P/E)9.7

Beta0.22

Next Earnings

Mar 11, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)5.55

Shares Outstanding14,032,930

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-0.38

Price to Book (P/B)0.52

Price to Sales (P/S)0.13

P/FCF Ratio14.73

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)10.9

Revenue Forecast (FY)€7.72B

Bulls Say, Bears Say

Bulls Say

Diversified Dairy ChannelsA combination of branded consumer products and recurring professional and industrial demand gives Savencia several routes to market. This channel diversity can support resilience across customer groups and reduce reliance on a single sales format over the next several quarters.

Established Revenue ScaleThe multi-year increase in revenue through 2024 shows that Savencia has maintained meaningful operating scale and demand across its dairy portfolio. That established base can support continued distribution, brand investment and recovery efforts if recent pressure moderates.

Manageable LeverageLeverage remains moderate for the business, while relatively stable equity provides a financial foundation during weaker earnings periods. This balance-sheet position preserves more flexibility than a highly indebted structure for funding operations and managing near-term volatility.

Bears Say

2025 Revenue DeclineThe reversal from several years of revenue growth to a 2.8% decline signals weaker recent demand or product performance. If sustained, lower sales would reduce operating leverage and make it harder for Savencia to absorb fixed costs or expand earnings.

Thin And Compressed ProfitabilityA very thin net margin leaves limited protection against cost pressure and weaker sales. The simultaneous compression of EBIT and EBITDA margins suggests reduced operating leverage, making durable earnings improvement dependent on restoring profitability rather than simply maintaining revenue scale.

Weak Cash ConversionWeak conversion of accounting earnings into free cash flow reduces the funds available for debt reduction, dividends and reinvestment. Continued inconsistency could constrain strategic flexibility and increase dependence on improved operating performance to finance the business internally.

Savencia News

Savencia Lifts Revenue on Chocolate Acquisitions Amid Weak Core Dairy Demand

The latest announcement is out from Savencia ( ($FR:SAVE) ). Savencia reported revenue of €5.423 billion at end‑September...

15d ago

Savencia’s Half-Year Results Show Acquisition-Driven Growth Amid Margin and Debt Pressures

The latest update is out from Savencia ( ($FR:SAVE) ). Savencia reported first-half 2026 sales of €3.486 billion,...

2M ago

Savencia Updates Share Capital and Voting Rights as of July 2026

Savencia ( ($FR:SAVE) ) has provided an update. Savencia reported that as of July 31, 2026, its share...

3M ago

Savencia (0DTK) Reveals Q2 Dividend: Here’s the Essential Information

Savencia (LSE: 0DTK) has declared, under its dividend policy, a yearly cash dividend in the amount of €1.60...

2y ago

BGJ FAQ

What was Savencia SA’s price range in the past 12 months?

Savencia SA lowest stock price was €53.80 and its highest was €73.60 in the past 12 months.

What is Savencia SA’s market cap?

Savencia SA’s market cap is €768.04M.

When is Savencia SA’s upcoming earnings report date?

Savencia SA’s upcoming earnings report date is Mar 11, 2027 which is in 133 days.

How were Savencia SA’s earnings last quarter?

Savencia SA released its earnings results on Sep 10, 2026. The company reported €2.913 earnings per share for the quarter.

Is Savencia SA overvalued?

According to Wall Street analysts Savencia SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Savencia SA pay dividends?

Savencia SA does not currently pay dividends.

What is Savencia SA’s EPS estimate?

Savencia SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Savencia SA have?

Savencia SA has 14,032,930 shares outstanding.

What happened to Savencia SA’s price movement after its last earnings report?

Savencia SA reported an EPS of €2.913 in its last earnings report. Following the earnings report the stock price went up 0.325%.

Which hedge fund is a major shareholder of Savencia SA?

Currently, no hedge funds are holding shares in DE:BGJ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Savencia SA

Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.